688 related articles for article (PubMed ID: 33164929)
1. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
Jääskeläinen O; Hall A; Tiainen M; van Gils M; Lötjönen J; Kangas AJ; Helisalmi S; Pikkarainen M; Hallikainen M; Koivisto A; Hartikainen P; Hiltunen M; Ala-Korpela M; Soininen P; Soininen H; Herukka SK
J Alzheimers Dis; 2020; 74(1):277-286. PubMed ID: 32007958
[TBL] [Abstract][Full Text] [Related]
3. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
[TBL] [Abstract][Full Text] [Related]
5. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
Liu Y; Li N; Zhou L; Li Q; Li W
Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
[TBL] [Abstract][Full Text] [Related]
7. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
Trushina E; Dutta T; Persson XM; Mielke MM; Petersen RC
PLoS One; 2013; 8(5):e63644. PubMed ID: 23700429
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning.
Wang Y; Sun Y; Wang Y; Jia S; Qiao Y; Zhou Z; Shao W; Zhang X; Guo J; Zhang B; Niu X; Wang Y; Peng D
Alzheimers Res Ther; 2023 Nov; 15(1):191. PubMed ID: 37925455
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls.
Jasbi P; Shi X; Chu P; Elliott N; Hudson H; Jones D; Serrano G; Chow B; Beach TG; Liu L; Jentarra G; Gu H
J Proteome Res; 2021 Sep; 20(9):4303-4317. PubMed ID: 34355917
[TBL] [Abstract][Full Text] [Related]
10. A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
Massetti N; Russo M; Franciotti R; Nardini D; Mandolini GM; Granzotto A; Bomba M; Delli Pizzi S; Mosca A; Scherer R; Onofrj M; Sensi SL; ;
J Alzheimers Dis; 2022; 85(4):1639-1655. PubMed ID: 34958014
[TBL] [Abstract][Full Text] [Related]
11. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
[TBL] [Abstract][Full Text] [Related]
12. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
Mandal PK; Saharan S; Tripathi M; Murari G
Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
[TBL] [Abstract][Full Text] [Related]
13. Application of advanced machine learning methods on resting-state fMRI network for identification of mild cognitive impairment and Alzheimer's disease.
Khazaee A; Ebrahimzadeh A; Babajani-Feremi A
Brain Imaging Behav; 2016 Sep; 10(3):799-817. PubMed ID: 26363784
[TBL] [Abstract][Full Text] [Related]
14. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
[TBL] [Abstract][Full Text] [Related]
15. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
[TBL] [Abstract][Full Text] [Related]
16. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
[TBL] [Abstract][Full Text] [Related]
17. Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography-Tandem Mass Spectrometry.
Inoue M; Suzuki H; Meno K; Liu S; Korenaga T; Uchida K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685872
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease.
Huang YL; Lin CH; Tsai TH; Huang CH; Li JL; Chen LK; Li CH; Tsai TF; Wang PN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681563
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
Kim SH; Yang JS; Lee JC; Lee JY; Lee JY; Kim E; Moon MH
J Chromatogr A; 2018 Sep; 1568():91-100. PubMed ID: 30007793
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
